Cardiovascular Research Associates Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2009
NCT00988585
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

icosapent ethyl (vascepa) (2 trials)

Drugs in Other Trials (1)

efalex (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2